Success Metrics

Clinical Success Rate
88.2%

Based on 15 completed trials

Completion Rate
88%(15/17)
Active Trials
1(5%)
Results Posted
53%(8 trials)
Terminated
2(10%)

Phase Distribution

Ph phase_2
9
43%
Ph phase_1
2
10%
Ph phase_3
2
10%
Ph phase_4
5
24%
Ph not_applicable
2
10%

Phase Distribution

2

Early Stage

9

Mid Stage

7

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
2(10.0%)
Phase 2Efficacy & side effects
9(45.0%)
Phase 3Large-scale testing
2(10.0%)
Phase 4Post-market surveillance
5(25.0%)
N/ANon-phased studies
2(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.2%

15 of 17 finished

Non-Completion Rate

11.8%

2 ended early

Currently Active

1

trials recruiting

Total Trials

21

all time

Status Distribution
Active(1)
Completed(15)
Terminated(2)
Other(3)

Detailed Status

Completed15
Terminated2
Suspended2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
1
Success Rate
88.2%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (10.0%)
Phase 29 (45.0%)
Phase 32 (10.0%)
Phase 45 (25.0%)
N/A2 (10.0%)

Trials by Status

unknown15%
terminated210%
recruiting15%
suspended210%
completed1571%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT05355272Phase 2

Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)

Recruiting
NCT06354023Phase 2

Human Growth Hormone Injections in the Knee Joint to Treat Osteoarthritis

Suspended
NCT00684957Phase 1

Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors

Terminated
NCT04003207Phase 2

Growth Hormone Treatment in Children With Phelan McDermid Syndrome

Completed
NCT05353192Phase 4

A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia

Unknown
NCT05105685Phase 1

Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS

Completed
NCT01811576Phase 2

Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency

Completed
NCT00283595Phase 2

Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa

Completed
NCT00182091Not Applicable

Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency

Completed
NCT00766038Phase 2

Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.

Completed
NCT03717168Phase 2

Effects of Growth Hormone on Difficult Ventilator Weaning Patients

Completed
NCT00957671Phase 4

Anterior Pituitary Hormone Replacement in Traumatic Brain Injury

Completed
NCT00194883Phase 4

Effect of Cytokines on Growth of Children With Chronic Kidney Failure

Suspended
NCT00067860Phase 2

Diet/Growth Factor Mechanisms of Gut Adaptation

Completed
NCT00443144

D3-GHR Polymorphism and Turner Syndrome

Completed
NCT00109733Phase 3

Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency

Completed
NCT00100698Not Applicable

Physiologic Growth Hormone Effects in HIV Lipodystrophy

Completed
NCT00287677Phase 4

Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected Patients

Completed
NCT00183040Phase 2

HORMA: Hormonal Regulators of Muscle and Metabolism in Aging

Completed
NCT00781547Phase 3

Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus

Completed

Drug Details

Intervention Type
DRUG
Total Trials
21